Christina Aungst, PharmDChristina Aungst, PharmD March 31, 2021, 3:35PM (PT) Key takeaways: Ponvory is a once-daily oral tablet that was recently approved by the FDA to treat relapsing multiple sclerosis (MS). Ponvory’s most common side effect is a higher risk of infections, especially upper respiratory infections. In studies, Ponvory was better at preventing multiple sclerosis...
AMERICAN HEART ASSOCIATION DALLAS, Nov. 9, 2020 — The new, investigational heart medication mavacamten may improve key structural abnormalities of obstructive hypertrophic cardiomyopathy, a condition characterized by thickened heart muscle that obstructs pumping of blood through the heart, according to research from the Phase 3 EXPLORER-HCM trial, to be presented at the American Heart Association’s Scientific Sessions...
